Calgary, Canada -
The people behind the company StemTech (multilevel marketing of a product called StemEnhance which supposedly increases circulating stem cells by mobilization) have published a paper describing possible mechanism of action for their stem cell mobilizer
(Jensen et al. Mobilization of human CD34CD133 and CD34CD133 stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae-related to modulation of CXCR4 expression by an L-selectin ligand? Cardiovasc Revasc Med. 2007 July - September;8(3):189-202).
The scientists demonstrated that their natural extract suppressed the induced expression of CXCR4 using in vitro cell line models. Additionally they did a 12 healthy volunteer crossover study and showed a transient increase in circulating CD34 cells 1 hour after administration.
We at StemCellPatents.com would really appreciate if someone left a comment to explain to the community the significance of mobilization levels between those achieved with this product compared to exercise, compared to G-CSF administration.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.